The table below shows GILEAD SCIENCES, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$2.54B
$1.76B
$2.22B
$1.74B
$1.84B
$2.61B
Capital expenditure
$117.00M
$104.00M
$105.00M
$109.00M
$247.00M
$165.00M
Investing cash flow
$1.77B
-$415.00M
-$2.21B
-$826.00M
-$1.07B
-$2.04B
Dividends paid
$1.04B
$1.01B
$990.00M
$969.00M
GILD operating cash flow (10-K history)
GILEAD SCIENCES, INC. reported operating cash flow of $10.02B for fiscal year 2025. That is down 7.5% from $10.83B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $17.05B (FY 2016) to $10.02B. Figures come from the company's audited annual reports as filed with the SEC.
